Lucid Diagnostics Inc. — Director's Dealing 2022

Aug 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2022-08-02

Reporting Person: White Debra (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-02	Employee stock option (right to buy)	$2.95	A	80000	Acquired	2032-08-02	Common stock (80000)	Direct

Footnotes

F1: The option vests in 12 quarterly installments, with first installment vesting September 30, 2022.